Impedimed Limited(IPDQF)
$0.00-0.00 (-13.33%)
IPDQF
Impedimed Limited financials statements
$0.00
At close:-0.00 (-13.33%)
Impedimed Limited (IPDQF) Ratios
25 Followers
Impedimed Limited Ratios
IPDQF's free cash flow for Q4 2026 was AU$0.00. For the 2026 fiscal year, IPDQF's free cash flow was increased by AU$10.53M and operating cash flow was AU$-10.53M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.81 | 4.86 | 6.33 | 8.88 | 6.44 |
| Quick Ratio | 3.45 | 4.71 | 6.16 | 8.75 | 6.32 |
| Cash Ratio | 2.48 | 3.92 | 5.29 | 7.82 | 5.62 |
| Solvency Ratio | -1.02 | -0.88 | -2.81 | -2.30 | -2.23 |
| Operating Cash Flow Ratio | -3.24 | -2.59 | -3.82 | -3.09 | -2.16 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | AU$ -945.00K | AU$ 6.35M | AU$ 23.21M | AU$ 44.08M | AU$ 39.01M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.48 | 0.35 | 0.02 | 0.02 | 0.00 |
| Debt-to-Equity Ratio | 1.63 | 0.71 | 0.03 | 0.02 | 0.00 |
| Debt-to-Capital Ratio | 0.62 | 0.41 | 0.03 | 0.02 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.61 | 0.40 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 3.40 | 2.03 | 1.15 | 1.13 | 1.15 |
| Debt Service Coverage Ratio | -5.62 | -16.07 | -227.05 | -557.00 | -609.89 |
| Interest Coverage Ratio | -5.93 | -22.15 | -204.69 | -671.94 | -758.11 |
| Debt to Market Cap | 1.51 | 0.20 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.06 | 0.44 | 1.07 | 2.16 | 2.17 |
| Profitability Margins | |||||
| Gross Profit Margin | -81.36% | 86.25% | 87.27% | -120.36% | -126.35% |
| EBIT Margin | -151.27% | -173.82% | -235.53% | -202.69% | -203.83% |
| EBITDA Margin | -151.27% | -137.95% | -213.69% | -180.65% | -176.51% |
| Operating Profit Margin | -151.27% | -190.44% | -184.48% | -201.39% | -200.90% |
| Pretax Profit Margin | -178.54% | -182.42% | -200.84% | -194.61% | -202.98% |
| Net Profit Margin | -170.44% | -182.62% | -191.78% | -180.90% | -188.09% |
| Continuous Operations Profit Margin | -170.44% | -182.62% | -191.78% | -180.90% | -188.09% |
| Net Income Per EBT | 95.47% | 100.11% | 95.49% | 92.96% | 92.67% |
| EBT Per EBIT | 118.03% | 95.79% | 108.87% | 96.63% | 101.04% |
| Return on Assets (ROA) | -71.86% | -55.78% | -42.12% | -29.85% | -33.86% |
| Return on Equity (ROE) | -244.50% | -113.37% | -48.57% | -33.71% | -38.94% |
| Return on Capital Employed (ROCE) | -77.60% | -67.31% | -44.97% | -36.33% | -41.25% |
| Return on Invested Capital (ROIC) | -73.32% | -66.82% | -42.61% | -33.61% | -38.10% |
| Return on Tangible Assets | -101.69% | -80.98% | -63.92% | -40.05% | -44.46% |
| Earnings Yield | -233.41% | -32.88% | -13.79% | -6.33% | -19.41% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.12 | 4.29 | 3.90 | 2.95 | 3.09 |
| Payables Turnover | 18.40 | 1.65 | 1.20 | 18.45 | 9.07 |
| Inventory Turnover | 11.99 | 2.03 | 1.73 | 30.86 | 25.83 |
| Fixed Asset Turnover | 22.59 | 14.41 | 7.13 | 5.81 | 25.28 |
| Asset Turnover | 0.42 | 0.31 | 0.22 | 0.17 | 0.18 |
| Working Capital Turnover Ratio | 0.75 | 0.55 | 0.29 | 0.27 | 0.37 |
| Cash Conversion Cycle | 127.46 | 43.91 | 0.05 | 115.69 | 91.81 |
| Days of Sales Outstanding | 116.85 | 85.03 | 93.66 | 123.65 | 117.94 |
| Days of Inventory Outstanding | 30.45 | 179.68 | 210.83 | 11.83 | 14.13 |
| Days of Payables Outstanding | 19.83 | 220.79 | 304.44 | 19.78 | 40.26 |
| Operating Cycle | 147.30 | 264.71 | 304.50 | 135.48 | 132.07 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -298.97 | -14.81 | -5.73 | -2.99 | -3.00 |
| Capital Expenditure Coverage Ratio | -298.97 | -14.81 | -5.73 | -2.99 | -3.00 |
| Operating Cash Flow Coverage Ratio | -1.21 | -1.01 | -15.56 | -12.47 | -92.14 |
| Operating Cash Flow to Sales Ratio | -1.37 | -1.15 | -1.72 | -1.59 | -1.48 |
| Free Cash Flow Yield | -188.34% | -22.12% | -14.56% | -7.43% | -20.39% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.43 | -3.04 | -7.25 | -15.79 | -5.15 |
| Price-to-Sales (P/S) Ratio | 0.73 | 5.55 | 13.91 | 28.57 | 9.69 |
| Price-to-Book (P/B) Ratio | 1.05 | 3.45 | 3.52 | 5.32 | 2.01 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.53 | -4.52 | -6.87 | -13.45 | -4.90 |
| Price-to-Operating Cash Flow Ratio | -0.53 | -4.83 | -8.07 | -17.95 | -6.54 |
| Price-to-Earnings Growth (PEG) Ratio | -0.25 | -0.20 | 0.59 | 4.66 | 0.16 |
| Enterprise Value Multiple | -0.54 | -3.59 | -5.44 | -13.65 | -3.32 |
| Enterprise Value | 11.98M | 62.98M | 120.05M | 279.80M | 61.86M |
| EV to EBITDA | -0.54 | -3.59 | -5.44 | -13.65 | -3.32 |
| EV to Sales | 0.82 | 4.95 | 11.63 | 24.66 | 5.85 |
| EV to Free Cash Flow | -0.60 | -4.03 | -5.75 | -11.61 | -2.96 |
| EV to Operating Cash Flow | -0.60 | -4.30 | -6.75 | -15.50 | -3.95 |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 |
| Shareholders’ Equity Per Share | 0.00 | 0.01 | 0.02 | 0.03 | 0.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.05 | -0.00 | 0.05 | 0.07 | 0.07 |
| Revenue Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Income Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Tax Burden | 0.95 | 1.00 | 0.95 | 0.93 | 0.93 |
| Interest Burden | 1.18 | 1.05 | 0.85 | 0.96 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.01 | 0.02 | 0.05 | 0.06 |
| SG&A to Revenue | 0.69 | 1.75 | 2.14 | 1.72 | 1.85 |
| Stock-Based Compensation to Revenue | 0.00 | 0.13 | -0.07 | 0.07 | 0.28 |
| Income Quality | 0.80 | 0.63 | 0.90 | 0.88 | 0.79 |
Currency in AUD
